Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

Controlled Trial ◽

Severe Osteoporosis ◽

Double Blind ◽

Menopausal Women ◽

Post Menopausal ◽

Faculty Opinions recommendation of Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732110937.793540256 ◽

2017 ◽

Author(s):

Jon Tobias ◽

Ben Faber

Keyword(s):

Controlled Trial ◽

Severe Osteoporosis ◽

Double Blind ◽

Menopausal Women ◽

Post Menopausal ◽

Does menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial

BMC Women s Health ◽

10.1186/s12905-016-0311-9 ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 6

Author(s):

Charlotte Ganderton ◽

Adam Semciw ◽

Jill Cook ◽

Tania Pizzari

Keyword(s):

Hormone Therapy ◽

Controlled Trial ◽

Pain Syndrome ◽

Menopausal Hormone Therapy ◽

Greater Trochanteric Pain Syndrome ◽

Menopausal Women ◽

Post Menopausal ◽

Randomised Controlled ◽

And Function

Effects of exercise on bone density and falls risk factors in post-menopausal women with osteopenia: A randomised controlled trial

Journal of Science and Medicine in Sport ◽

10.1016/j.jsams.2011.08.007 ◽

2012 ◽

Vol 15 (2) ◽

pp. 102-109 ◽

Cited By ~ 30

Author(s):

Karen L. Bolton ◽

Thorlene Egerton ◽

John Wark ◽

Elin Wee ◽

Bernadette Matthews ◽

...

Keyword(s):

Risk Factors ◽

Bone Density ◽

Controlled Trial ◽

Falls Risk ◽

Menopausal Women ◽

Post Menopausal ◽

A MULTICENTRE DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL TO ASSESS THE CLINICAL- AND COST-EFFECTIVENESS OF FACET-JOINT INJECTIONS IN PATIENTS WITH NON-SPECIFIC LOW BACK PAIN: A FEASIBILITY STUDY

10.26226/morressier.59ad4811d462b80290b53a8a ◽

2017 ◽

Author(s):

Ahmad Alia

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Cost Effectiveness ◽

Facet Joint ◽

Controlled Trial ◽

Low Back ◽

Double Blind ◽

Randomised Controlled ◽

Joint Injections

Faculty Opinions recommendation of TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1058963.510919 ◽

2007 ◽

Author(s):

Pascal Derkinderen

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

Faculty Opinions recommendation of The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955094.793462652 ◽

2012 ◽

Author(s):

Chim Lang

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

Faculty Opinions recommendation of Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718482844.793498728 ◽

2014 ◽

Author(s):

Carlos Seas ◽

Joel Lopez

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Faculty Opinions recommendation of Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725669310.793559015 ◽

2019 ◽

Author(s):

Stefan De Hert

Keyword(s):

Coronary Artery ◽

Coronary Artery Bypass ◽

Coronary Artery Bypass Surgery ◽

Myocardial Injury ◽

Bypass Surgery ◽

Controlled Trial ◽

Artery Bypass ◽

Double Blind ◽

Faculty Opinions recommendation of Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725552213.793516915 ◽

2016 ◽

Author(s):

Bradley Quon

Keyword(s):

Cystic Fibrosis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Faculty Opinions recommendation of High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7746956.8077054 ◽

2011 ◽

Cited By ~ 1

Author(s):

Willem J Wiersinga ◽

Gavin Koh

Keyword(s):

Vitamin D ◽

Controlled Trial ◽

Antimicrobial Treatment ◽

High Dose ◽

Double Blind ◽

Intensive Phase ◽

Vitamin D 3 ◽

Randomised Controlled ◽

High Dose Vitamin